Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine infiltration for pudendal neuralgia
NCT06872437Phase 3Recruiting
- Sponsor
- Groupe Hospitalier Diaconesses Croix Saint-Simon
- Start
- Dec 2023
- Primary completion
- Mar 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lidocaine in pudendal neuralgia (PN), sponsored by Groupe Hospitalier Diaconesses Croix Saint-Simon. Started Dec 2023; status: recruiting.
02
Drugs
lidocaine
03
Conditions
pudendal neuralgia (PN)
Beyond the preview
Go deeper on NCT06872437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06872437.